Abstract
The overall prevalence of postpartum depression is estimated at 100-150 cases per 1000 births, and one of the most indicated drugs for treatment is Venlafaxine, a Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs). As serotonin plays a key role in brain development, studies have shown that prenatal exposure to SSRIs can alter the hypothalamic-pituitary-adrenal (HHA) and gonadal (HHG…